More articles from MINIREVIEW

You have access
Implications of autophagy and apoptosis in tumorgenesis; Possible alterations in autophagy through engineered nanomaterials and their importance in cancer therapy
Habib Ghaznavi, Milad Shirvaliloo, Amir Zarebkohan, Zinat Shams, Fateme Radina, Zahra Bahmanpour, Saman Sargazi, Ramin Saravani, ‪Sakine Shirvalilou, Omolbanin Shahraki, Sheida Shahraki, Ziba Nazarlou and Roghayeh Sheervalilour

Molecular Pharmacology May 14, 2021, MOLPHARM-MR-2021-000234; DOI: https://doi.org/10.1124/molpharm.121.000234
You have access
Update on Angiotensin II Subtype 2 Receptor: Focus on Peptide and Non-peptide Agonists
Arina Ranjit, Sana Khajehpour and Ali Aghazadeh-Habashi

Molecular Pharmacology April 1, 2021, MOLPHARM-MR-2021-000236; DOI: https://doi.org/10.1124/molpharm.121.000236
You have access
The Emerging Role of Neuronal Organoid Models in Drug Discovery: Potential Applications and Hurdles to Implementation
Laura A. Struzyna and Marla L. Watt

Molecular Pharmacology April 2021, 99 (4) 256-265; DOI: https://doi.org/10.1124/molpharm.120.000142
You have access
Arrestin-Dependent and -Independent Internalization of G Protein–Coupled Receptors: Methods, Mechanisms, and Implications on Cell Signaling
Ee Von Moo, Jeffrey R. van Senten, Hans Bräuner-Osborne and Thor C. Møller

Molecular Pharmacology April 2021, 99 (4) 242-255; DOI: https://doi.org/10.1124/molpharm.120.000192
You have access
Molecular Mechanisms for the Inflammation-Resolving Actions of Lenabasum
Sumner Burstein

Molecular Pharmacology February 2021, 99 (2) 125-132; DOI: https://doi.org/10.1124/molpharm.120.000083
You have access
Targeting Angiotensin-Converting Enzyme-2/Angiotensin-(1-7)/Mas Receptor Axis in the Vascular Progenitor Cells for Cardiovascular Diseases
Yagna P.R. Jarajapu

Molecular Pharmacology January 2021, 99 (1) 29-38; DOI: https://doi.org/10.1124/mol.119.117580
You have access
Dysregulation of Angiotensin Converting Enzyme 2 Expression and Function in Comorbid Disease Conditions Possibly Contributes to Coronavirus Infectious Disease 2019 Complication Severity
Safaa H Hammoud, Zena Wehbe, Samar Abdelhady, Firas Kobeissy, Ali H. Eid and Ahmed F. El-Yazbi

Molecular Pharmacology January 2021, 99 (1) 17-28; DOI: https://doi.org/10.1124/molpharm.120.000119
You have access
Heparin-binding Peptides as Novel Therapies to Stop SARS-CoV-2 Cellular Entry and Infection
Omid Tavassoly, Farinaz Safavi and Iman Tavassoly

Molecular Pharmacology November 2020, 98 (5) 612-619; DOI: https://doi.org/10.1124/molpharm.120.000098
You have access
Molecular Pharmacology of NRH:Quinone Oxidoreductase 2: A Detoxifying Enzyme Acting as an Undercover Toxifying Enzyme
Elzbieta Janda, Françoise Nepveu, Barbara Calamini, Gilles Ferry and Jean A. Boutin

Molecular Pharmacology November 2020, 98 (5) 620-633; DOI: https://doi.org/10.1124/molpharm.120.000105
You have access
Functions of the CXCL12 Receptor ACKR3/CXCR7—What Has Been Perceived and What Has Been Overlooked
Christian Koch and Jürgen Engele

Molecular Pharmacology November 2020, 98 (5) 577-585; DOI: https://doi.org/10.1124/molpharm.120.000056

Main menu

User menu

Search

More articles from MINIREVIEW

Pages

Navigate

More Information

ASPET's Other Journals